Skip to main content

Peer Review reports

From: A novel 11β-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49 improves hyperglycemia, lipid profile and reduces body weight in diet induced obese C57B6/J mice with a potential to provide cardio protective benefits

Original Submission
7 Feb 2014 Submitted Original manuscript
7 Feb 2014 Author responded Author comments - B P SOMESH
Resubmission - Version 2
7 Feb 2014 Submitted Manuscript version 2
25 Feb 2014 Reviewed Reviewer Report - Matthew Whittaker
13 Jun 2014 Author responded Author comments - B P SOMESH
Resubmission - Version 3
13 Jun 2014 Submitted Manuscript version 3
25 Jun 2014 Reviewed Reviewer Report - Matthew Whittaker
8 Jul 2014 Author responded Author comments - B P SOMESH
Resubmission - Version 4
8 Jul 2014 Submitted Manuscript version 4
15 Jul 2014 Author responded Author comments - B P SOMESH
Resubmission - Version 5
15 Jul 2014 Submitted Manuscript version 5
23 Jul 2014 Author responded Author comments - B P SOMESH
Resubmission - Version 6
23 Jul 2014 Submitted Manuscript version 6
Publishing
29 Jul 2014 Editorially accepted
7 Aug 2014 Article published 10.1186/2050-6511-15-43

You can find further information about peer review here.

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us